Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07089602 · ClinicalTrials.gov registry record · Phase 4
Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers
A Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, sponsored by BioLab Holdings.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 650
- Enrollment target
- 1
- Study location
NCT07089602 is a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer that is actively recruiting participants, run by BioLab Holdings. The registered enrollment target is 650 participants, above the 245-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (165% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07089602, a Phase 4 study of Diabetic Foot Ulcer and Venous Leg Ulcer, is actively recruiting participants, sponsored by BioLab Holdings.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 650 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the efficacy of human placental membrane products and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
Conditions Studied
Interventions
- OTHER Standard of Care DFU
- OTHER Tri-Membrane Wrap™ DFU
- OTHER Membrane Wrap™ DFU
- OTHER Membrane Wrap-Lite™ DFU
- OTHER Membrane Wrap-Hydro™ DFU
Study Locations (1)
Pennsylvania
- Center for Foot and Ankle Disorders - Philidelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2027-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07089602
The ClinicalTrials.gov registry entry for NCT07089602 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 245-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (165% higher). The listed sponsor is BioLab Holdings, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 9 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 5 interventions - of which Standard of Care DFU is the first listed.
NCT07089602 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07089602 about?
NCT07089602 is a clinical study titled "Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers". The purpose of this study is to evaluate the efficacy of human placental membrane products and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers.
What is the current status of trial NCT07089602?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 650 participants. The study started on 2025-07-15. Estimated completion is 2027-07.
What conditions does trial NCT07089602 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Venous Leg Ulcer, Diabetic Foot, Ulcer, Ulcer Foot.
What interventions are being tested in trial NCT07089602?
The interventions under investigation include: Standard of Care DFU (OTHER), Tri-Membrane Wrap™ DFU (OTHER), Membrane Wrap™ DFU (OTHER), Membrane Wrap-Lite™ DFU (OTHER), Membrane Wrap-Hydro™ DFU (OTHER).
Who is sponsoring clinical trial NCT07089602?
This trial is sponsored by BioLab Holdings, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07089602 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
RECRUITING · Phase 4
-
A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.
RECRUITING · Phase 4
-
Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers
ACTIVE NOT RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.